AVERSA Fentanyl

AVERSA Fentanyl is an investigational pharmaceutical product that combines Nutriband's proprietary AVERSA abuse-deterrent transdermal technology with Kindeva Drug Delivery's FDA-approved fentanyl patch system. The core innovation of the product is a proprietary aversive agent coating, designed to deter oral abuse and accidental exposure by employing taste aversion. This technology does not alter the drug layer itself but adds a physical barrier to prevent misuse, diversion, and accidental ingestion of potent opioids like fentanyl. The platform can be adapted for other drugs at risk of abuse in transdermal patches (e.g., buprenorphine, methylphenidate). The development pathway leverages a 505(b)(2) regulatory strategy requiring only Phase 1 human abuse potential studies prior to submission. If approved, it would be the first opioid patch with explicit abuse-deterrence properties[1][3][4][5].

Brand names

AVERSAAVERSA Fentanyl

Other names

Aversa abuse-deterrent fentanyl patchAversa abuse-deterrent transdermal technology